172
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Comparison of statistical methods for predicting penetration capacity of drugs into human breast milk using physicochemical, pharmacokinetic and chromatographic descriptors

ORCID Icon, &
Pages 457-475 | Received 12 Apr 2020, Accepted 18 May 2020, Published online: 05 Jul 2020

References

  • M.H. Abraham, J. Gil-Lostes, and M. Fatemi, Prediction of milk/plasma concentration ratios of drugs and environmental pollutants, Eur. J. Med. Chem. 44 (2009), pp. 2452–2458. doi:10.1016/j.ejmech.2009.01.009.
  • J.T. Wilson, R.D. Brown, D.R. Cherek, J.W. Dailey, B. Hilman, P.C. Jobe, B.R. Manno, J.E. Manno, H.M. Redetzki, and I.J. Stewart, Drug excretion in human breast milk: Principles, pharmacokinetics and projected consequences, Clin. Pharmacokinet. 5 (1980), pp. 1–66. doi:10.2165/00003088-198005010-00001.
  • T. Peck, S. Hill, and M. Williams, Drug passage across the cell membrane, in Pharmacology for Anaesthesia and Intensive Care, 3rd ed., Cambridge University Press, Cambridge, UK, 2008, pp. 1–10.
  • F. Kratz and B. Elsadek, Clinical impact of serum proteins on drug delivery, J. Contr. Rel. 161 (2012), pp. 429–445. doi:10.1016/j.jconrel.2011.11.028.
  • C. Bertucci and E. Domenici, Reversible and covalent binding of drugs to human serum albumin: Methodological approaches and physiological relevance, Curr. Med. Chem. 9 (2012), pp. 1463–1481. doi:10.2174/0929867023369673.
  • P. Routledge, The plasma protein binding of basic drugs, Br. J. Clin. Pharmacol. 22 (1986), pp. 499–506. doi:10.1111/j.1365-2125.1986.tb02927.x.
  • R. Lauterbach, Stosowanie leków a karmienie piersią, Pediatr. Po Dyplomie 15 (2011), pp. 77–85.
  • N.J. Yang and M.J. Hinner, Getting across the cell membrane: An overview for small molecules, peptides, and proteins, Meth. Mol. Biol. 1266 (2015), pp. 29–53.
  • S. Gentile, A. Rossi, and C. Bellantuono, SSRIs during breastfeeding: Spotlight on milk-to-plasma ratio, Arch. Womens Ment. Health 10 (2007), pp. 39–51. doi:10.1007/s00737-007-0173-0.
  • M.S. Meskin and E.J. Lien, QSAR analysis of drug excretion into human breast milk, J. Clin. Pharm. Ther. 10 (1985), pp. 269–278. doi:10.1111/j.1365-2710.1985.tb00924.x.
  • E. Begg, H. Atkinson, and S. Duffull, Prospective evaluation of a model for the prediction of milk: Plasma drug concentrations from physicochemical characteristics, Br. J. Clin. Pharmacol. 33 (1992), pp. 501–505. doi:10.1111/j.1365-2125.1992.tb04077.x.
  • U.C. Atkinson and E.J. Begg, Prediction of drug distribution into human milk from physicochemical characteristics, Clin. Pharmacokinet 18 (1990), pp. 151–167. doi:10.2165/00003088-199018020-00005.
  • S. Agatonovic-Kustrin, I.G. Tucker, M. Zecevic, and L.J. Zivanovic, Prediction of drug transfer into human milk from theoretically derived descriptors, Anal. Chim. Acta 418 (2000), pp. 181–195. doi:10.1016/S0003-2670(00)00963-6.
  • A.R. Katritzky, D.A. Dobchev, E. Hür, D.C. Fara, and M. Karelson, QSAR treatment of drugs transfer into human breast milk, Bioorg. Med. Chem. 13 (2005), pp. 1623–1632. doi:10.1016/j.bmc.2004.12.015.
  • T.W. Hale, Medications and Mother’s Milk, 15th ed., Pharmasoft Medical Publishing, Amarillo, TX, 2012.
  • E. Ayranci and O. Duman, Binding of fluoride, bromide and iodide to bovine serum albumin, studied with ion-selective electrodes, Food Chem. 84 (2004), pp. 539–543. doi:10.1016/S0308-8146(03)00276-0.
  • J.A. Platts, M.H. Abraham, Y.H. Zhao, A. Hersey, L. Ijaz, and D. Butina, Correlation and prediction of a large blood-brain distribution data set - An LFER study, Eur. J. Med. Chem. 36 (2001), pp. 719–730. doi:10.1016/S0223-5234(01)01269-7.
  • H.H. Usansky and P.J. Sinko, Computation of log BB values for compounds transported through carrier-mediated mechanisms using in vitro permeability data from brain microvessel endothelial cell (BMEC) monolayers, Pharm. Res. 20 (2003), pp. 390–396. doi:10.1023/A:1022647903205.
  • S. Vilar, M. Chakrabarti, and S. Costanzi, Prediction of passive blood-brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptors, J. Mol. Graph. Model. 28 (2010), pp. 899–903. doi:10.1016/j.jmgm.2010.03.010.
  • Drugbank. Available at https://www.drugbank.ca/drugs/DB01174.
  • Chembl database. available at https://www.ebi.ac.uk/chembl/.
  • Drugs and lactation database (LactMed). available at https://toxnet.nlm.nih.gov/pda/lactmed.htm.
  • D.E. Clark, Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration, J. Pharm. Sci. (1999), pp. 815–821. doi:10.1021/js980402t.
  • S. Ozeki, and K. Tejima, Drug interactions. II. Binding of some pyrazolone and pyrazolidine derivatives to bovine serum albumin, Chem. Pharm. Bull. 22 (1974), pp. 1297–1301. doi:10.1248/cpb.22.1297.
  • A.W. Sobańska, A. Hekner, and E. Brzezińska, RP-18 HPLC analysis of drugs’ ability to cross the blood-brain barrier, J. Chem. (2019), pp. 1–12. doi:10.1155/2019/5795402.
  • A.W. Sobańska, K. Wanat, and E. Brzezińska, Prediction of the blood-brain barrier permeability using RP-18 thin layer chromatography, Open Chem. 17 (2019), pp. 43–56. doi:10.1515/chem-2019-0005.
  • A. Tropsha, Best practices for QSAR model development, validation, and exploitation, Mol. Inform. 29 (2010), pp. 476–488. doi:10.1002/minf.201000061.
  • R. Kiralj and M.M.C. Ferreira, Basic validation procedures for regression models in QSAR and QSPR studies: Theory and application, J. Braz. Chem. Soc. 20 (2009), pp. 770–787. doi:10.1590/S0103-50532009000400021.
  • S. Wold, Validation of QSAR’s, Quant. Struct. Relat. 10 (1991), pp. 191–193. doi:10.1002/qsar.19910100302.
  • K.V. Mardia, J.T. Kent, and J.M. Bibbly, Multivariate Analysis, Academic Press, New York, 1979.
  • P. Geladi and B.R. Kowalski, Partial least-squares regression: A tutorial, Anal. Chim. Acta 185 (1986), pp. 1–17. doi:10.1016/0003-2670(86)80028-9.
  • A. Cutler, D.R. Cutler, and J.R. Stevens, Random forests, in Ensemble Machine Learning: Methods and Applications, New York, USA,  2012, pp. 157–175.
  • T. Ghafourian and Z. Amin, QSAR models for the prediction of plasma protein binding, BioImpacts 3 (2013), pp. 21–27. doi:10.5681/bi.2013.011.
  • J.R. Votano, M. Parham, L.M. Hall, L.H. Hall, L.B. Kier, S. Oloff, and A. Tropsha, QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation, J. Med. Chem. 49 (2006), pp. 7169–7181. doi:10.1021/jm051245v.
  • R. Davanzo, S. Dal, B.J. Bua, M. Copertino, E. Zanelli, and L. Matarazzo, Antiepileptic drugs and breastfeeding, Ital. J. Pediatr. 39 (2013), pp. 1–11. doi:10.1186/1824-7288-39-50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.